A Promise Without Panacea: Psychedelic-Assisted Therapies in Modern Psychiatry.
Cureus 2026 Mohsin Raza, Jasleen Kaur
Psychedelic-assisted therapies have re-emerged as a subject of increasing scientific and clinical interest in psychiatry, particularly in the context of persistent treatment gaps for conditions such as treatment-resistant depression, post-traumatic stress disorder, and substance use disorders. Compounds, including psilocybin and 3,4-methylenedioxymethamphetamine, are being evaluated in...
DOI: 10.7759/cureus.102421 (opens in new tab)
Full text (opens in new tab)
Lysergic acid diethylamide
Psilocybin
Psychedelic-assisted psychotherapy
4-Methylenedioxymethamphetamine MDMA
+3